Allergan PLC is recalling nearly 170,000 sample packs of its birth-control treatment Taytulla after placebo and active capsules were placed out of order, potentially raising the risk of an unintended pregnancy.
The drugmaker said Tuesday the physician sample packs of Taytulla were designed to have 24 active birth control pills, followed by four placebo pills, taken daily over the course of 28 days. Allergan, which attributed the issue to a packing error, said the four inactive pills were incorrectly placed at the start of...